?? Building a Competitive & Innovative Pharmaceutical Ecosystem for the EU ??
Jonathan Dickinson
Chief Executive Officer and Chairman of the Board at Innate Pharma Talks about #oncology, #hematology, #IAI, #rarediseases and #leadership
?? I am proud to join innovative pharmaceutical companies in signing @EUCOPE’s open letter to EU Institutions and Member States, calling for a future-proofed ecosystem that allows innovation, research, and access to cutting-edge therapies, including for rare diseases.?
?? Together, we call on the leaders of the EU Institutions to take decisive action, ensuring the EU leads the way in pharmaceutical innovation on the global stage. A stronger, more supportive ecosystem will enable groundbreaking advancements that improve patients’ lives across Europe and beyond.
#PharmaInnovation #EUPharma #InnovationEcosystem #RareDiseases
Read the open letter here: https://www.eucope.org/building-a-competitive-and-attractive-pharmaceutical-ecosystem-in-the-eu/